CD11c antibody - HS-375 008

CD11c is a fibrinogen receptor involved in cell-cell interaction during inflammation
Rabbit monoclonal recombinant IgG
Cat. No.: HS-375 008
Amount: 50 µg
Price: $415.00
Cat. No. HS-375 008 50 µg purified recombinant IgG, lyophilized. Albumin and azide were added for stabilization. For reconstitution add 50 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
WB: not recommended
IP: not tested yet
ICC: not tested yet
IHC: 1 : 500 up to 1 : 2500 (see remarks) gallery  
IHC-P: 1 : 400 up to 1 : 2000 gallery  
Clone Rb322C12
Subtype IgG1 (κ light chain)
Immunogen Synthetic peptide corresponding to residues surrounding AA 647 of mouse CD11c (UniProt Id: Q9QXH4)
Reactivity Reacts with: mouse (Q9QXH4).
No signal: human (P20702), rat (D3ZWZ1).
Other species not tested yet.
Remarks

This antibody is a chimeric antibody based on the monoclonal rat antibody SY-322C12. The constant regions of the heavy and light chains have been replaced by rabbit specific sequences. The antibody can therefore be used with standard anti-rabbit secondary reagents. The antibody has been expressed in mammalian cells.
IHC: Heat-mediated antigen retrieval (citrate buffer pH 6) is required for immunohistochemical staining.

Data sheet hs-375_008.pdf
Cat. No.: HS-375 008
Amount: 50 µg
Price: $415.00

CD11c (red) and CD11b (green) positive cells in a mouse spleen

Background

CD11c or Integrin alpha-X (ITGAX) is a heterodimeric glycoprotein consisting of an α- and β-subunit and has seven repeating integrin domains. This transmembrane receptor type I plays a pivotal role in T cell killing and mediates intercellular adhesions during inflammation. Predominat expression levels have been found in dendritic cells, monocytes, macrophages, neutrophils and a small subset of B cells. Under pathological conditions, CD11c is a marker for hairy cell leukemia, acute non-lymphocytic leukemias, and some chronic lymphocytic leukemias.